Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
Julphar
US Department of Justice
Mallinckrodt
McKinsey
Chubb
Medtronic
Novartis
Federal Trade Commission
Healthtrust

Generated: January 19, 2018

DrugPatentWatch Database Preview

Details for Patent: 3,982,021

« Back to Dashboard

Summary for Patent: 3,982,021
Title: Compositions for the treatment of coronary diseases containing tetrahydronaphthyloxy-aminopropanols
Abstract:This invention relates to pharmaceutical compositions for the treatment of coronary diseases comprising a compound having the formula ##SPC1## Wherein R.sup.1 is lower alkyl, R.sup.3, R.sup.4, R.sup.5, R.sup.6 and R.sup.7 are the same or different and are hydrogen or lower alkyl, and R.sup.8, R.sup.9 and R.sup.10 are the same or different and are hydrogen, lower alkyl, lower alkoxy or cycloalkyl; and a pharmaceutically acceptable carrier therefor.
Inventor(s): Hauck; Frederic P. (Somerville, NJ), Cimarusti; Christopher M. (Hamilton, NJ), Narayanan; Venkatachala L. (Hightstown, NJ)
Assignee: E. R. Squibb & Sons, Inc. (Princeton, NJ)
Application Number:05/621,176
Patent Claim Types:
see list of patent claims
Use; Composition; Compound;

Drugs Protected by US Patent 3,982,021

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 3,982,021

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 198638 ➤ Subscribe
Argentina 198639 ➤ Subscribe
Belgium 849191 ➤ Subscribe
Canada 979912 ➤ Subscribe
Canada 979926 ➤ Subscribe
Switzerland 548978 ➤ Subscribe
Switzerland 550770 ➤ Subscribe
Germany 2130393 ➤ Subscribe
Germany 2167224 ➤ Subscribe
Germany 2258995 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Julphar
Moodys
Teva
Colorcon
Accenture
AstraZeneca
Cantor Fitzgerald
Citi
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot